Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07250958 · ClinicalTrials.gov registry record
Dome-Only Aneurysm Coiling in Severe Aneurysmal Subarachnoid Hemorrhage
A clinical trial, sponsored by University of Louisville.
- Recruiting
- Registry status
- 30
- Enrollment target
NCT07250958: Recruiting study, sponsored by University of Louisville.
NCT07250958 is a clinical trial that is actively recruiting participants, run by University of Louisville. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07250958 is actively recruiting participants, sponsored by University of Louisville.
- RECRUITING
- Registry status
- 30 participants
- Enrollment target
Study Summary
The DOME study is a clinical trial exploring a new treatment approach for patients who suffered a severe brain bleed due to an aneurysm.
Primary Outcome
Detected on head CT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-03-12 |
| Est. Completion | 2027-01 |
What NCT07250958 shows while recruiting
NCT07250958 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT07250958 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07250958 about?
NCT07250958 is a clinical study titled "Dome-Only Aneurysm Coiling in Severe Aneurysmal Subarachnoid Hemorrhage". The DOME study is a clinical trial exploring a new treatment approach for patients who suffered a severe brain bleed due to an aneurysm.
What is the current status of trial NCT07250958?
This trial is currently recruiting. The enrollment target is 30 participants. The study started on 2026-03-12. Estimated completion is 2027-01.
Who is sponsoring clinical trial NCT07250958?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI